REGENERON PHARMACEUTICALS

REGN · NASDAQ

Updated at 2026-11-16 23:31:40

$952.40-0.32%
Today's High
$972.24
Today’s Low
$947.81
REGENERON PHARMACEUTICALS (REGN) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$952.47
Previous Close
$955.47
Volume
1.16M
Market Cap
$98.84B
P/E Ratio
20.51X
EPS
$45.28

Previous Day Range

$942.00$961.94

52-Week Range

$591.52$991.73

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, UNITED STATES, 10591-6707
Country
US
Listing Date
1991-04-02
Fiscal Year End
December
Shares Outstanding
103.45M
CIK
0000872589

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors.

Financial Metrics

Revenue

2026-09-30

$5.11B

2026-06-30

$4.29B

2026-03-31

$3.6B

2025-12-31

$3.88B

Operating Expenses

2026-09-30

$2.49B

2026-06-30

$2.29B

2026-03-31

$2.29B

2025-12-31

$2.41B

Net Income

2026-09-30

$1.94B

2026-06-30

$1.29B

2026-03-31

$727.2M

2025-12-31

$844.6M

Net Profit Margin

2026-09-30

38.09%

2026-06-30

30.22%

2026-03-31

20.16%

2025-12-31

21.74%

Earnings Per Share

2026-09-30

$18.43

2026-06-30

$12.53

2026-03-31

$9.47

2025-12-31

$11.44

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-09-30

$2.41B

2026-06-30

$1.66B

2026-03-31

$967.3M

2025-12-31

$1.2B

Effective Tax Rate

2026-09-30

14.68%

2026-06-30

15.11%

2026-03-31

12.51%

2025-12-31

19.07%

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.